New Product Development
[297 Pages Report] The global glucose sensor market is expected to be worth $7,588 million in 2022. Between 2022 and 2032, global sales of glucose sensors are expected to grow at an 8.6% CAGR, reaching around US$ 16,382 million by the end of 2032. Diabetes mellitus is one of the most widely prevalent endocrine disorder …
Continue reading “Glucose Sensor Market reaching around US$ 16,382 million by the end of 2032 | FMI”
[320 Pages Report] In 2022, the global healthcare IT outsourcing market is expected to be worth $50,025.3 million. In the healthcare industry, outsourcing IT solutions has emerged as an effective way to reduce rising healthcare costs while meeting the growing demand for excellent care. Future Market Insights, in its latest business report, elaborates on the …
[308 Pages Report] In 2022, the global intraoperative radiation therapy systems market is expected to be worth US$ 55.9 million. The application of therapeutic stages of radiation to the tumour site is known as IORT. IORT is frequently used in the multidisciplinary treatment of privately advanced and recurring disease, alongside outer beam radiation, chemotherapy, and …
[256 Pages Report] The global preclinical imaging market is expected to be worth US$ 3.3 billion in 2022, and to grow at a CAGR of 3.5% to be worth US$ 4.7 billion by the end of 2032. According to a recent study by Future Market Insights, MRI imaging will lead the global preclinical imaging market …
[300 Pages Report] In 2022, the global palliative care market is expected to be worth US$ 13,087.9 million. Palliative care is given to patients suffering from diseases such as cancer, congestive heart failure (CHF), CNS disorders, chronic pulmonary obstructive disease (COPD), and others, and it includes symptomatic relief for nausea and vomiting, diarrhoea, pain and …
[422 Pages Report] The global vascular endothelial growth factor inhibitors market is expected to be worth US$ 22.7 billion by the end of 2022, and to grow at a CAGR of 4.0% to be worth US$ 33.5 billion by 2032. According to a recent study by Future Market Insights, biologics are leading the market as …
According to the forecast, Japan will hold the largest market during the forecast period. Changing lifestyles, a growing geriatric population, and increasing occurrence of dental decay are expected to lead to market growth in the region. Increasing health awareness in Japan will provide better growth opportunities for dental adhesives in the market. Social media trends …
Antiepileptic drugs market are usually referred as anti-seizure drugs market, which is developed as a part of the asymptomatic and Idiopathic treatment of epileptic seizures. The epileptic seizures demonstrate repeating acts and happen because of wrong sign directed by nerve cells to the brain. Antiepileptic drugs are also used in the treatment of neuropathic pain. Past …
[286 Pages Report] The global demand for monoclonal antibodies market is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 647.01 Billion in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6.1%. …
[281 Pages Report] The market for mobile clinics is anticipated to achieve a worth of US$ 2.8 billion by the end of 2022 and to continue growing at a CAGR of 11.3% to reach an estimated valuation of US$ 8.1 billion by 2032. Rise in demand to provide healthcare facilities in rural remote areas has boost …